Jordan Gotti holds a BSc degree in Biotechnology and a MSc degree in Industrial Biotechnology at the University of Milan. She worked for one year as a research fellow at San Raffaele Telethon Institute for Gene Therapy (SR-Tiget, Milan, Italy) in the Safety of Gene Therapy and Insertional Mutagenesis Unit in a project that aimed to use cfDNA as an early response biomarker to evaluate the safety and efficacy of CAR-T cell therapy.